| Dr Marko Vasic, MD | |
|
302 California Ave Ste 106, Wahiawa, HI 96786-1841 | |
| (808) 622-1618 | |
| Not Available |
| Full Name | Dr Marko Vasic |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 302 California Ave Ste 106, Wahiawa, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720431695 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD-21994 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wahiawa General Hospital | Wahiawa, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Wahiawa Center For Community Health | 6608154182 | 9 |
News Archive
English schoolgirls are less satisfied with their lives than boys and feel more pressure to succeed at school – a report authored by University of Hertfordshire researchers has revealed.
Researchers from the University of Tsukuba show that long stretches of repeat DNA sequences in the gene FLI1 are associated with susceptibility to systemic sclerosis.
Simulators have long been used for training surgeons and surgical teams, but traditional simulator platforms typically have a built-in limitation: they often simulate one or a limited number of conditions that require performance of isolated tasks, such as placing an intravenous catheter, instead of simulating and providing opportunities for feedback on the performance of multiple interventions that a trauma victim may require at the same time.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
The National Institutes of Health (NIH) has awarded a five-year, $5.5 million Transformative Research Project (T-R01) Award to fund research into risk factors for spina bifida and related congenital defects in which an area of the affected baby's spine or brain is not fully enclosed.
› Verified 4 days ago
| Entity Name | The Wahiawa Center For Community Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992176283 PECOS PAC ID: 6608154182 Enrollment ID: O20161108001466 |
News Archive
English schoolgirls are less satisfied with their lives than boys and feel more pressure to succeed at school – a report authored by University of Hertfordshire researchers has revealed.
Researchers from the University of Tsukuba show that long stretches of repeat DNA sequences in the gene FLI1 are associated with susceptibility to systemic sclerosis.
Simulators have long been used for training surgeons and surgical teams, but traditional simulator platforms typically have a built-in limitation: they often simulate one or a limited number of conditions that require performance of isolated tasks, such as placing an intravenous catheter, instead of simulating and providing opportunities for feedback on the performance of multiple interventions that a trauma victim may require at the same time.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
The National Institutes of Health (NIH) has awarded a five-year, $5.5 million Transformative Research Project (T-R01) Award to fund research into risk factors for spina bifida and related congenital defects in which an area of the affected baby's spine or brain is not fully enclosed.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marko Vasic, MD 302 California Ave Ste 106, Wahiawa, HI 96786-1841 Ph: () - | Dr Marko Vasic, MD 302 California Ave Ste 106, Wahiawa, HI 96786-1841 Ph: (808) 622-1618 |
News Archive
English schoolgirls are less satisfied with their lives than boys and feel more pressure to succeed at school – a report authored by University of Hertfordshire researchers has revealed.
Researchers from the University of Tsukuba show that long stretches of repeat DNA sequences in the gene FLI1 are associated with susceptibility to systemic sclerosis.
Simulators have long been used for training surgeons and surgical teams, but traditional simulator platforms typically have a built-in limitation: they often simulate one or a limited number of conditions that require performance of isolated tasks, such as placing an intravenous catheter, instead of simulating and providing opportunities for feedback on the performance of multiple interventions that a trauma victim may require at the same time.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
The National Institutes of Health (NIH) has awarded a five-year, $5.5 million Transformative Research Project (T-R01) Award to fund research into risk factors for spina bifida and related congenital defects in which an area of the affected baby's spine or brain is not fully enclosed.
› Verified 4 days ago
Baron Ckw Wong, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 128 Lehua St Fl 1, Wahiawa, HI 96786 Phone: 808-621-4120 | |
Dr. Edmund S.m. Whang, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 34 Makani Ave, Wahiawa, HI 96786 Phone: 808-622-4191 Fax: 808-621-5742 | |
Josephine Dela Torre Waite, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 916 Kilani Ave, Wahiawa, HI 96786 Phone: 808-621-5042 Fax: 808-621-9313 | |
Dr. Gildo Sabanpan Soriano, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 916 Kilani Ave, Wahiawa, HI 96786 Phone: 808-621-5042 Fax: 808-621-9313 | |
Arnold Seid, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 960 Center St Ste 7, Wahiawa, HI 96786 Phone: 808-621-6511 Fax: 808-622-9088 |